{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:11:44Z","timestamp":1778821904539,"version":"3.51.4"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.carrev.2025.09.007","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:43:15Z","timestamp":1757781795000},"page":"10-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Editorial: Left atrial appendage occlusion, antiplatelets and anticoagulants"],"prefix":"10.1016","volume":"86","author":[{"given":"David","family":"Hildick-Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2025.09.007_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carrev.2025.07.012","article-title":"Outcomes for single antiplatelet, dual antiplatelet, or oral anticoagulation after Amulet: insights from EMERGE LAA post-approval study","volume":"86","author":"Shah","year":"2025","journal-title":"Cardiovasc Revasc Med"},{"issue":"9689","key":"10.1016\/j.carrev.2025.09.007_bb0010","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.carrev.2025.09.007_bb0015","doi-asserted-by":"crossref","first-page":"e2138","DOI":"10.4244\/EIJ-D-17-00901","article-title":"Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices","volume":"13","author":"Weise","year":"2018","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.carrev.2025.09.007_bb0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/00015385.2018.1455946","article-title":"Dual antiplatelet therapy after percutaneous left atrial appendage occlusion: single center experience with the Amplatzer Cardiac Plug","volume":"74","author":"Bertrand","year":"2019","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.carrev.2025.09.007_bb0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.amjcard.2020.08.013","article-title":"Safety and efficacy of single versus dual antiplatelet therapy after left atrial appendage occlusion","volume":"134","author":"Patti","year":"2020","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.carrev.2025.09.007_bb0030","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.4244\/EIJ-D-23-00684","article-title":"Single antiplatelet therapy following amplatzer left atrial appendage occlusion","volume":"20","author":"Kramer","year":"2024","journal-title":"EuroIntervention"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925004701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925004701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:28:18Z","timestamp":1778819298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838925004701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":6,"alternative-id":["S1553838925004701"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2025.09.007","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editorial: Left atrial appendage occlusion, antiplatelets and anticoagulants","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2025.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}